2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1
Adenoviridae Infections
1
Interventions
pembrolizumab
1280
Specimen Handling
928
Carboplatin
836
Magnetic Resonance Spectroscopy
831
Cyclophosphamide
807
Cisplatin
735
Nivolumab
679
Paclitaxel
634
Radiotherapy
617
Gemcitabine
579
Biopsy
560
Bevacizumab
486
Dexamethasone
444
fludarabine
409
Docetaxel
385
venetoclax
372
Oxaliplatin
367
Capecitabine
363
Fluorouracil
358
atezolizumab
353
durvalumab
339
Rituximab
335
Drug Therapy
333
Radiosurgery
321
Doxorubicin
320
Blood Specimen Collection
315
Standard of Care
311
Pemetrexed
308
Ipilimumab
303
Radiation
289
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Tumor Necrosis Factor-alpha
×
1 year
×
Clear all
NCT04695327
2026-03-06
TUNIMO
TILT Biotherapeutics Ltd.
Phase 1
Completed
32 enrolled
NCT05222932
2025-08-07
AVENTIL
TILT Biotherapeutics Ltd.
Phase 1
Active not recruiting
15 enrolled